This is a list of all the questions and their associated study carrel identifiers. One can learn a lot of the "aboutness" of a text simply by reading the questions.
| identifier | question |
|---|---|
| cord-000072-2ygb80sc | Angiopoietin signalling in critical illness – a future target? |
| cord-000072-2ygb80sc | attenuation by dexamethasone Inhibition of in vivo tumor angiogenesis and growth via systemic delivery of an angiopoietin 2-specific RNA aptamer Therapeutic application of RNAi: is mRNA targeting finally ready for prime time? |
| cord-016335-z2movens | Why are angiotensin concentrations so high in the kidney? |
| cord-017585-0llgr357 | Comparison of omapatrilat and the novel neutral endopeptidase 24.11/ angiotensin- converting enzyme inhibitor GW796406 NF- kappaB- dependent increase in intrarenal angiotensin II induced by proteinuria Angiotensin-(1- 7) inhibits growth of cardiac myocytes through activation of the mas receptor Differential regulation of cardiac angiotensin converting enzyme 2( ACE2) and ACE by aldosterone Characterization of renal Angiotensin- converting enzyme 2 in diabetic nephropathy Developmental expression of ACE2 in the SHR kidney: A role in hypertension? |
| cord-006082-x1kankxd | A decade of research: what have we learned? |
| cord-006082-x1kankxd | type 2 receptor agonist compound 21 reduces vascular injury and myocardial fibrosis in stroke- prone spontaneously hypertensive rats Angiotensin II type 2 receptor stimulation: a novel option of therapeutic interference with the renin- angiotensin system in myocardial infarction? |
| cord-006439-q7m4srvp | New technologies are making it easier to answer old questions- what is the localization of angiotensin receptors- and investigate new ones- what are function of specific subsets of AT 1 R- containng neurons? |
| cord-006439-q7m4srvp | provides a novel look at angiotensin type-2 receptor distribution in the central nervous system A unique"angiotensin- sensitive"neuronal population coordinates neuroendocrine, cardiovascular, and behavioral responses to stress Expression of AT2 receptors in the developing rat fetus Tonin expression in the rat brain and toninmediated central production of angiotensin II Extrarenal angiotensin- forming enzymes Angiotensin generation in the brain and drinking: indications for the involvement of endopeptidase activity distinct from cathepsin D Chronic immunoneutralization of brain angiotensin-(1- 12) lowers blood pressure in transgenic( mRen2)27 hypertensive rats Brain renin- angiotensin system: does it exist? |
| cord-002632-6he8sjpf | An FDA overview of rodent carcinogenicity studies of angiotensin II AT-1 receptor blockers: pulmonary adenomas and carcinomas Renin- angiotensin system blockade for the risk of cancer and death Angiotensin receptor blockers( ARBs) reduce the risk of lung cancer: a systematic review and meta- analysis Long term use of drugs affecting the renin- angiotensin system and the risk of cancer: a population- based case- control study Angiotensin receptor blockers: are they related to lung cancer? |
| cord-002632-6he8sjpf | Angiotensin receptors: a new role in cancer? |
| cord-002632-6he8sjpf | The reninangiotensin system and cancer: old dog, new tricks G- protein coupled receptors of the renin- angiotensin system: New targets against breast cancer? |
| cord-002307-gk84fnb9 | -friend or foe? |
| cord-002307-gk84fnb9 | The brain renin- angiotensin system: a diversity of functions and implications for CNS diseases Brain renin angiotensin in disease Angiotensin-(1- 7): a novel peptide to treat hypertension and nephropathy in diabetes? |
| cord-298490-p1msabl5 | Human intestine luminal ACE2 and amino acid transporter expression increased by ACE- inhibitors Imbalance of the renin- angiotensin system may contribute to inflammation and fibrosis in IBD: a novel therapeutic target? |
| cord-273595-fkk4ry62 | The expression and localization of the human placental prorenin/ renin- angiotensin system throughout pregnancy: roles in trophoblast invasion and angiogenesis? |
| cord-310124-3bc8zeww | A novel method for isolation of pluripotent stem cells from human umbilical cord blood Dynamics of bone marrow VSELs and HSCs in response to treatment with gonadotropin and steroid hormones, during pregnancy and evidence to support their asymmetric/ symmetric cell divisions Molecular and phenotypic characterization of CD133 and SSEA4 enriched very small embryonic- like stem cells in human cord blood Functional testing of primitive oocyte- like cells developed in ovarian surface epithelium cell culture from small VSEL- like stem cells: Can they be fertilized one day? |
| cord-028640-kxrmzyo8 | The Wnt/ Frizzled pathway as a therapeutic target for cardiac hypertrophy: where do we stand? |
| cord-005931-iggkxbbf | Alcohol intake ANG II induces drinking, but does it induce alcohol drinking? |
| cord-005931-iggkxbbf | But, what about renin? |
| cord-291146-f3e5ynhu | A pilot clinical trial of recombinant human angiotensin- converting enzyme 2 in acute respiratory distress syndrome Sars- CoV-2 and the black population ACE2 as shield or blade? |
| cord-006087-hynkb0a8 | Angiotensin II suppression in humans by the orally active renin inhibitor aliskiren( SPP100): comparison with enalapril Vasopeptidase inhibition and angio- oedema β- amyloid catabolism: roles for neprilysin( NEP) and other metallopeptidases? |
| cord-006087-hynkb0a8 | Human performance: a role for the ACE genotype? |
| cord-006087-hynkb0a8 | Omapatrilat-the story of Overture and Octave Vasopeptidase inhibition: a double- edged sword? |
| cord-006087-hynkb0a8 | Randomized evaluation of strategies for left ventricular dysfunction( RESOLVD) pilot study Can angiotensin receptor antagonists be used safely in patients with previous ACE inhibitor- induced angioedema? |
| cord-297178-moxhk2e0 | In sick adults, the Ang 1- 7 level is also high when compared to healthy subjects[ 68, 69], but the response intensity is much lower when compared to dogs and Covid-19 brings the world economy to its knees If the world fails to protect the economy, COVID-19 will damage health not just now but also in the future Developing a sustainable exit strategy for COVID-19: health, economic and public policy implications System Blockers and the Risk of Covid-19 Renin- Angiotensin- Aldosterone System Inhibitors in Patients with Covid-19 ACE2: The key Molecule for Understanding the Pathophysiology of Severe and Critical Conditions of COVID-19: Demon or Angel? |
| cord-297178-moxhk2e0 | Pulmonary Vascular Thrombosis, and Angiogenesis in Covid-19 Roles of RUNX in Hypoxia- Induced Responses and Angiogenesis Hypoxia Inducible Factor Pathway and Physiological Adaptation: A Cell Survival Pathway? |
| cord-007707-c38fu1jv | Any value of podocyte B7- 1 as a biomarker in human MCD and FSGS? |
| cord-007707-c38fu1jv | The podocyte's response to injury: role in proteinuria and glomerulosclerosis Podocyte as the target for aldosterone: roles of oxidative stress and Sgk1 Minimal change disease: a"two- hit"podocyte immune disorder? |
| cord-007707-c38fu1jv | in angiotensin II- induced reactive oxygen species generation and podocyte apoptosis Epithelial- to- mesenchymal transition in diabetic nephropathy: fact or fiction? |
| cord-007707-c38fu1jv | the culprit? |
| cord-278265-hgggkr5y | Renin- angiotensin- aldosterone system inhibitors in patients with Covid-19 SARS- CoV-2 cell entry depends on ACE2 and TMPRSS2 and is blocked by a clinically proven protease inhibitor Cardiovascular disease, drug therapy, and mortality in Covid-19 Do the SGLT-2 inhibitors offer more than hypoglycemic activity? |
| cord-277766-rxmpi61o | The( pro)renin receptor: a new addition to the renin- angiotensin system? |
| cord-259933-ggx4v0bz | key: cord-259933-ggx4v0bz authors: Dalan, Rinkoo; Bornstein, Stefan R.; El- Armouche, Ali; Rodionov, Roman N; Markov, Alexander; Wielockx, Ben; Beuschlein, Felix; Boehm, Bernhard O. title: The ACE-2 in COVID-19: Foe or Friend? |
| cord-015859-5kt59ose | ACE inhibitors correlates with ACE C- and N- domain blockade ACE- versus chymase- dependent angiotensin II generation in human coronary arteries: a matter of efficiency? |
| cord-015859-5kt59ose | Evidence for a C- terminal transmembrane anchor and for a proteolytic processing of the secreted recombinant and plasma enzymes Differential distribution of angiotensin AT2 receptors in the normal and failing human heart Angiotensin AT2 receptors: cardiovascular hope or hype? |
| cord-015859-5kt59ose | I Angiotensin converting enzyme is the main contributor to angiotensin I- II conversion in the interstitium of the isolated perfused rat heart Angiotensin receptors: a new role in cancer? |
| cord-015859-5kt59ose | receptor- mediated vasodilation in the heart: effect of myocardial infarction Cardiac angiotensin II: an intracrine hormone? |
| cord-015859-5kt59ose | which angiotensin receptor is the culprit in cardiac hypertrophy? |
| cord-291137-09a3tblt | The acute respiratory distress syndrome Angiotensin converting enzyme defects in shock: implications for future therapy Reversal of vasodilatory shock: current perspectives on conventional, rescue, and emerging vasoactive agents for the treatment of shock Renin as a marker of tissue- perfusion and prognosis in critically ill patients Bradykinin, angiotensin-(1- 7), and ACE inhibitors: how do they interact? |
| cord-333580-tw9cehxv | The second point that needs correction is the suggestion that angiotensin receptor blockers( ARBs) cause a reduction in Ang II levels( plasma, tissue?) |
| cord-299960-ounktxxv | The cardiovascular effects of angiotensin-(1- 7) in the rostral and caudal ventrolateral medulla of the rabbit Does angiotensin II have a significant tonic action on cardiovascular neurons in the rostral and caudal VLM? |
| cord-311099-59pnm4fn | ACE inhibition Gradual reactivation of vascular angiotensin I to angiotensin II conversion during chronic ACE inhibitor therapy in patients with diabetes mellitus Determinants of increased angiotensin II levels in severe chronic heart failure patients despite ACE inhibition How often are angiotensin II and aldosterone concentrations raised during chronic ACE inhibitor treatment in cardiac failure? |
| cord-311099-59pnm4fn | Bradykinin, angiotensin-(1- 7), and ACE inhibitors: how do they interact? |
| cord-311099-59pnm4fn | Liver fibrosis: a balance of ACEs? |
| cord-307894-pfsztifl | Cardiac overexpression of angiotensin converting enzyme 2 protects the heart from ischemia- induced pathophysiology Angiotensin- converting enzyme 2: cardioprotective player in the renin- angiotensin system? |
| cord-334717-zg9f19p8 | Helpful or harmful? |
| cord-326223-q6e60nf8 | Enhanced renal immunocytochemical expression of ANG-(1- 7) and ACE2 during pregnancy Novel aspects of the renal renin- angiotensin system: angiotensin-(1- 7), ACE2 and blood pressure regulation Vasopeptidase inhibitors: a new therapeutic concept in cardiovascular disease? |
| cord-326223-q6e60nf8 | The angiotensin- converting enzyme gene family: genomics and pharmacology Hydrolysis of biological peptides by human angiotensin- converting enzyme- related carboxypeptidase AT1 receptor blockade increases cardiac bradykinin via neutral endopeptidase after induction of myocardial infarction in rats Vasopeptidase inhibitors: will they have a role in clinical practice? |
| cord-276192-sgts963l | Angiotensin II generation in vivo: does it involve enzymes other than renin and angiotensin- converting enzyme? |
| cord-276192-sgts963l | Angiotensinogen- deficient mice exhibit impairment of diet- induced weight gain with alteration in adipose tissue development and increased locomotor activity Link between the reninangiotensin system and insulin resistance: implications for cardiovascular disease Renin angiotensin system in liver diseases: friend or foe? |
| cord-276192-sgts963l | The association between serum chloride levels and chronic kidney disease progression: a cohort study Increasing potassium intake to prevent kidney damage: a new population strategy? |
| cord-276192-sgts963l | immunopathology Do angiotensin type 2 receptors modulate haemodynamic effects of type 1 receptors in conscious newborn lambs? |
| cord-309619-glb2y82u | The antithrombotic effect of angiotensin-(1- 7) involves mas- mediated NO release from platelets High frequency of antiphospholipid antibodies in critically- ill COVID-19 patients: a link with hypercoagulability? |
| cord-309619-glb2y82u | risk factors in medical- surgical critically ill patients* multicenter study; randomized controlled trial Pulmonary thrombosis: a clinical pathological entity distinct from pulmonary embolism? |
| cord-309619-glb2y82u | rs12252-C is associated with disease severity in COVID-19 Genomewide Association study of severe Covid-19 with respiratory failure Use of reninÀangiotensinÀaldosterone system inhibitors and risk of COVID-19 requiring admission to hospital: a case- population study Novel antibody epitopes dominate the antigenicity of spike glycoprotein in SARS- CoV-2 compared to SARS- CoV Soluble angiotensin- converting enzyme 2: a potential approach for coronavirus infection therapy? |
| cord-320331-wtxja5i9 | Are patients with hypertension and diabetes mellitus at increased risk for COVID-19 infection? |
| cord-320331-wtxja5i9 | Can we contain the COVID-19 outbreak with the same measures as for SARS? |
| cord-339157-wj47xeqj | Severe hand, foot and mouth disease in Shenzhen, South China: what matters most? |
| cord-335076-mmpox655 | New approaches to blockade of the reninangiotensin- aldosterone system: chymase as an important target to prevent organ damage Endothelial dysfunction: a strategic target in the treatment of hypertension? |
| cord-314102-8jf3fnqe | In addition to the factors that connect the respiratory system with the external environment, is there any receptor other than ACE2 that mediates the invasion of 2019-nCoV into the host? |
| cord-317472-6ese0c0e | 10, 11 If ACE is the worst of enzymes, is ACE2 the best of enzymes? |
| cord-332716-1d89j7jh | Enzyme Inhibitors/ Angiotensin Receptor Blockers Have a Biphasic Effect? |
| cord-332716-1d89j7jh | and only proteolysis by TMPRSS2 augments entry driven by the severe acute respiratory syndrome coronavirus spike protein Clinical relevance and role of neuronal AT1 receptors in ADAM17-mediated ACE2 shedding in neurogenic hypertension Antihypertensive drugs and risk of COVID-19? |
| cord-313664-qq0h68vc | Arterial aging: is it an immutable cardiovascular risk factor? |
| cord-313664-qq0h68vc | Many questions are also raised, for instance, what would the consequences be if the'beneficial'angiotensin peptide, Ang 1- 7 was not generated at all or'benefical'AT2 receptor mediated effects disappeared completely? |
| cord-313664-qq0h68vc | Novel drugs targeting hypertension: renin inhibitors and beyond Dual blockade of the renin- angiotensin system with angiotensin- converting enzyme inhibitors and angiotensin II receptor blockers in chronic kidney disease Telmisartan, ramipril or both in patients at high risk for vascular events Antidiabetic mechanisms of angiotensin- converting enzyme inhibitors and angiotensin II receptor antagonists: beyond the renin- angiotensin system Renin inhibition with aliskiren: where are we now and where are we going? |
| cord-313664-qq0h68vc | Part of genetic reprogramming? |
| cord-313664-qq0h68vc | The adipose- tissue renin- angiotensin- aldosterone system: role in the metabolic syndrome? |
| cord-313664-qq0h68vc | angiotensin II- dependent or-independent mechanisms? |
| cord-291595-8241pjpe | A report of five cases C5a negatively regulates tolllike receptor 4-induced immune responses Regulation of Toll- like receptor- mediated inflammatory response by complement in vivo Complement as a target in COVID-19? |
| cord-291595-8241pjpe | Angiotensin II- induced hypertrophy of cultured murine proximal tubular cells is mediated by endogenous transforming growth factor- beta Angiotensin II sustains brain inflammation in mice via TGF- β Severe hypertension with renal thrombotic microangiopathy: what happened to the usual suspect? |
| cord-291595-8241pjpe | COVID-19: a case for inhibiting IL-17? |
| cord-291595-8241pjpe | Distinct immune response in two MERS- CoV- infected patients: can we go from bench to bedside? |
| cord-291595-8241pjpe | defined subsets, random expression, and external modulation IL-10 dampens TNF/ inducible nitric oxide synthaseproducing dendritic cell- mediated pathogenicity during parasitic infection Interleukin-10 and the regulation of mitogenactivated protein kinases: are these signalling modules targets for the anti- inflammatory action of this cytokine? |
| cord-291595-8241pjpe | to Prevent Lung Damage in SARSCoV2 Infection? |
| cord-342478-2k2eb1rk | ADAM17 interaction regulates the activity of presympathetic Ezrin, Radixin and Moesin: key regulators of membrane- cortex interactions and signaling Recent insights and therapeutic perspectives of angiotensin-(1- 9) in the cardiovascular system Rac regulates the interaction of fascin with protein kinase C in cell migration Dynamics of ADAM17-mediated shedding of ACE2 applied to pancreatic islets of male db/ db COVID-19, SARS and MERS: are they closely related? |
| cord-342478-2k2eb1rk | Clathrin/ AP-2-dependent endocytosis: a novel playground for the pharmacological toolbox? |
| cord-344012-npob20n0 | A first step in understanding SARS pathogenesis Restructuring of the gut microbiome by intermittent fasting prevents retinopathy and prolongs survival in db/ db mice Microbiome and diabetes: where are we now? |
| cord-344012-npob20n0 | COVID-19) A familial cluster of pneumonia associated with the 2019 novel coronavirus indicating person- to- person transmission: a study of a family cluster Viral shedding patterns of coronavirus in patients with probable severe acute respiratory syndrome Enteric involvement of severe acute respiratory syndrome- associated coronavirus infection Human intestinal tract serves as an alternative infection route for Middle East respiratory syndrome coronavirus Brain- gut- bone marrow axis: implications for hypertension and related therapeutics Prolonged presence of Sars- CoV-2 viral rna in faecal samples Enteric involvement of coronaviruses: is faecaloral transmission of SARS- CoV-2 possible? |
| cord-344012-npob20n0 | The renin- angiotensin system: going beyond the classical paradigms Emerging evidence for a functional angiotensin- converting enzyme 2-angiotensin-(1- 7)-MAS receptor axis: more than regulation of blood pressure? |
| cord-344012-npob20n0 | should inhibitors of the renin- angiotensin system be withdrawn in patients with covid-19? |
| cord-018009-8j40876m | ( PREAMI) Study A new hormone of the angiotensin system Long- term ACE- inhibitor therapy in patients with heart failure or left- ventricular dysfunction: a systematic overview of data from individual patients Signaling by the angiotensin- converting enzyme Direct myocardial and coronary effects of enalaprilat in patients with dilated cardiomyopathy: assessment by a bilateral intracoronary infusion technique Should angiotensin- converting enzyme- inhibitors be used to improve outcome in patients with coronary artery disease and'preserved'left ventricular function? |
| cord-018009-8j40876m | Angiotensin- converting enzyme inhibitors potentiate preconditioning through bradykinin B 2 receptor activation in human heart Are ACE inhibitors a"magic bullet"against oxidative stress? |
| cord-018009-8j40876m | Does the renin- angiotensin system exert an important stimulatory influence on the sympathetic nervous system? |
| cord-018009-8j40876m | Results of the survival and ventricular enlargement trial Effect of captopril on progressive ventricular dilatation after anterior myocardial infarction Valsartan, captopril, or both in myocardial infarction complicated by heart failure, left ventricular dysfunction, or both Survival after an experimental myocardial infarction: beneficial effects of long- term therapy with captopril ACE inhibitors for patients with vascular disease without left ventricular dysfunction- may they rest in PEACE? |
| cord-018009-8j40876m | The cardiac renin- angiotensin system: conceptual, or a regulator of cardiac function? |
| cord-018009-8j40876m | prevent restenosis after percutaneous transluminal coronary angioplasty? |
| cord-337678-vh6dpf4e | Are patients with hypertension and diabetes mellitus at increased risk for COVID-19 infection? |
| cord-337678-vh6dpf4e | Function 2020, 1, zqaa003 ion and redox homeostasis: How much do they really matter? |
| cord-337678-vh6dpf4e | Gene Mutations Driven by Their Effects on Intracellular pH, Their “ pH ” Enotype? date: 2020- 08- 07 journal: |
| cord-339752-o6atz33c | ACE2: The Key Molecule for Understanding the Pathophysiology of Severe and Critical Conditions of COVID-19: Demon or Angel? |
| cord-339752-o6atz33c | COVID-19 and the cardiovascular system Are patients with hypertension and diabetes mellitus at increased risk for COVID-19 infection? |
| cord-343225-8nxsrod5 | A paradigm shift? |
| cord-343225-8nxsrod5 | The cardiac renin- angiotensin system: conceptual, or a regulator of cardiac function? |
| cord-277669-uujny2dm | A Potential Approach for Coronavirus Infection Therapy? |
| cord-277669-uujny2dm | COVID-19 and Cardiovascular Disease: From Basic Mechanisms to Clinical Perspectives Macrophages: A Trojan Horse in COVID-19? |
| cord-277669-uujny2dm | Turk Innate Immune Signaling and Proteolytic Pathways in the Resolution or Exacerbation of SARS- CoV-2 in Covid-19: Key Therapeutic Targets? |
| cord-277669-uujny2dm | an Angiotensin II Receptor Blocker Are Patients With Hypertension and Diabetes Mellitus at Increased Risk for COVID-19 Infection? |
| cord-277669-uujny2dm | to Prevent Lung Damage in SARS- CoV-2 Infection? |
| cord-318327-9sh2eksm | Angiotensin II type 2 receptor stimulation: a novel option of therapeutic interference with the renin- angiotensin system in myocardial infarction? |
| cord-318327-9sh2eksm | Do inhibitors of angiotensin- Iconverting enzyme protect against risk of cancer? |
| cord-318327-9sh2eksm | Quantitative analysis by the polymerase chain reaction Angiotensin and cell growth: a link to cardiovascular hypertrophy? |
| cord-318327-9sh2eksm | myocardial ischemia/ reperfusion Angiotensin-(1- 7) inhibits growth of cardiac myocytes through activation of the mas receptor Emerging evidence for a functional angiotensin- converting enzyme 2-angiotensin-(1- 7)-MAS receptor axis: more than regulation of blood pressure? |
| cord-326405-3446eyi3 | Enhanced renal immunocytochemical expression of ANG-(1- 7) and ACE2 during pregnancy Renal ACE2 expression in human kidney disease? |
| cord-326405-3446eyi3 | This was the first demonstration that genetic Ace2 deficiency in diabetes is associated with ANG IIx- mediated acceleration of glomerular injury Angiotensinconverting enzyme 2 is an essential regulator of heart function Developmental expression of ACE2 in the SHR kidney: a role in hypertension? |
| cord-326405-3446eyi3 | What may be the significance of reduced ACE2 and increased ACE at the glomerular level? |
| cord-326405-3446eyi3 | a renoprotective combination? |
| cord-340581-ngwgb3y0 | ( Ciaglia et al., 2020) and reduce viral attachment to target cells as suggested in Figure 3? |
| cord-340581-ngwgb3y0 | ( Kai and Kai, 2020), or can we inhibit binding of SARS spike proteins to ACE2, for instance by antibodies, without hampering its catalytic capacities to generate Ang 1- 7? |
| cord-340581-ngwgb3y0 | Does it exert systemic vasodilation or improve the microcirculation? |
| cord-340581-ngwgb3y0 | Hemnes et al., 2018)? |
| cord-340581-ngwgb3y0 | Is there a role for testosterone? |
| cord-340581-ngwgb3y0 | The COVID-19 outbreak and the angiotensin- converting enzyme 2: too little or too much? |
| cord-340581-ngwgb3y0 | The lung macrophage in SARS- CoV-2 infection: a friend or a foe? |
| cord-340581-ngwgb3y0 | Why does COVID-19 kill more elderly men than women? |
| cord-340581-ngwgb3y0 | angiotensin- converting enzyme 2: an ally or a trojan horse? |
| cord-349445-yh6ndtgm | : What Is the Evidence? |
| cord-349445-yh6ndtgm | Are certain drugs associated with enhanced mortality in COVID-19? |
| cord-349445-yh6ndtgm | COVID-19: Epidemiology, Evolution, and Cross- Disciplinary Perspectives COVID-19 and the Renin- Angiotensin System SARS- CoV2: should inhibitors of the renin- angiotensin system be withdrawn in patients with COVID-19? |
| cord-349445-yh6ndtgm | Close to a Cure? |
| cord-349445-yh6ndtgm | Covid-19 Can angiotensin receptor- blocking drugs perhaps be harmful in the COVID-19 pandemic? |
| cord-349445-yh6ndtgm | Evidence- Based Med New insights on the antiviral effects of chloroquine against coronavirus: what to expect for COVID-19? |
| cord-349445-yh6ndtgm | Hence, the question now, may the reviewed actions of NEP pathways be sufficient to impose a new effective strategy for COVID-19 management as compared to the suggested repurposed drugs? |
| cord-349445-yh6ndtgm | Modulators of inflammation in acute lung injury? |
| cord-349445-yh6ndtgm | Neprilysin inhibition: a new therapeutic option for type 2 diabetes? |
| cord-349445-yh6ndtgm | Role in reducing β- amyloid levels Estrogen regulation of the neprilysin gene through a hormone- responsive element Influence of Selected Natural Products on Neutral Endopeptidase Activity and β- Amyloid Production in SK- N- SH Cells Possible role of Resveratrol targeting Estradiol and Neprilysin pathways in Lipopolysaccharide model of Alzheimer disease Epigallocatechin-3-gallate attenuates cognitive deterioration in Alzheimer's disease model mice by upregulating neprilysin expression Effects of Naoerkang on expressions of β- amyloid peptide 1- 42 and neprilysin in hippocampus in a rat model of Alzheimer's disease Decoding the enigma of antiviral crisis: Does one target molecule regulate all? |
| cord-349445-yh6ndtgm | So Far, Pathogens Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study COVID-19: consider cytokine storm syndromes and immunosuppression Correspondence Use of antiviral drugs to reduce COVID-19 Therapeutic options for the 2019 novel coronavirus( 2019-nCoV) Drug treatment options for the 2019-new coronavirus( 2019-nCoV) Molecular immune pathogenesis and diagnosis of COVID-19 Cytokinstormer ved covid-19? |
| cord-349445-yh6ndtgm | v2, ArXiv Prepr Acute respiratory distress syndrome leads to reduced ratio of ACE/ ACE2 activities and is prevented by angiotensin-(1- 7) or an angiotensin II receptor antagonist The Angiotensin- Converting Enzyme 2/ Angiogenesis-(1- 7)/Mas Axis Confers Cardiopulmonary Protection against Lung Fibrosis and Pulmonary Hypertension Decreased levels of serum Angiotensin-(1- 7) in patients with pulmonary arterial hypertension due to congenital heart disease Reninangiotensin- system, a potential pharmacological candidate, in acute respiratory distress syndrome during mechanical ventilation Dose- dependent, therapeutic potential of angiotensin-(1- 7) for the treatment of pulmonary arterial hypertension Angiotensin II type 2 receptor( AT2R) in renal and cardiovascular disease Angiotensin-(1- 7): A Novel Peptide to Treat Hypertension and Nephropathy in Diabetes? |